Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of TI-0032-III Injection for relapsed and refractory autoimmune diseases is currently recruiting, encompassing several autoimmune condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Inflammatory Myopathy
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• TI-0032-III Injection

Snippet

Sponsor: Therorna | Conditions: Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS) | Phase 1 | Status: RECRUITING